Viewing Study NCT02263105


Ignite Creation Date: 2025-12-25 @ 3:32 AM
Ignite Modification Date: 2026-04-07 @ 4:04 PM
Study NCT ID: NCT02263105
Status: COMPLETED
Last Update Posted: 2018-07-17
First Post: 2014-09-28
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Efficacy and Tolerability of Cisplatin Plus Alternating Weekly Temozolomide in Recurrent High-grade Gliomas
Sponsor: Huashan Hospital
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module